Market revenue in 2022 | USD 342.1 million |
Market revenue in 2030 | USD 513.5 million |
Growth rate | 5.2% (CAGR from 2022 to 2030) |
Largest segment | Morphine |
Fastest growing segment | Bupivacaine |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 31.48% in 2022. Horizon Databook has segmented the Global intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global intrathecal pumps market, including forecasts for subscribers. This global databook contains high-level insights into Global intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Type | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 113.9 | 117.9 | 122.4 | 77.7 | 131.9 | 137.3 | 142.4 | 148.2 | 154.5 | 160.9 | 167.6 | 174.7 | 182.4 | 190.4 | 4.2% |
Europe | 81.5 | 85.2 | 89.0 | 57.1 | 97.8 | 102.6 | 107.4 | 112.8 | 118.5 | 124.5 | 130.7 | 137.5 | 144.8 | 152.4 | 5.1% |
Asia Pacific | 51.9 | 55.4 | 59.2 | 38.6 | 67.6 | 72.1 | 77.1 | 82.5 | 88.1 | 94.3 | 101.0 | 107.9 | 115.5 | 123.9 | 7.0% |
Latin America | 13.9 | 14.6 | 15.3 | 9.9 | 17.2 | 18.2 | 19.0 | 20.1 | 21.2 | 22.5 | 23.8 | 25.1 | 26.5 | 28.1 | 5.6% |
MEA | 9.0 | 9.4 | 10.1 | 6.5 | 11.3 | 11.9 | 12.8 | 13.5 | 14.2 | 14.9 | 15.9 | 16.5 | 17.5 | 18.7 | 5.8% |
Overall | 270.2 | 282.5 | 296.0 | 189.8 | 325.8 | 342.1 | 358.7 | 377.1 | 396.5 | 417.1 | 439.0 | 461.7 | 486.7 | 513.5 | 5.2% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account